Table of Content


Introduction
Cytomegalovirus Infections - Overview
Cytomegalovirus Infections - Therapeutics Development
Cytomegalovirus Infections - Therapeutics Assessment
Cytomegalovirus Infections - Companies Involved in Therapeutics Development
Cytomegalovirus Infections - Drug Profiles
Cytomegalovirus Infections - Dormant Projects
Cytomegalovirus Infections - Discontinued Products
Cytomegalovirus Infections - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Cytomegalovirus (HHV-5) Infections, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Cytomegalovirus (HHV-5) Infections, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Abhelix LLC, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by AlloVir Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Artemis Therapeutics Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Atara Biotherapeutics Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Biotest AG, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Chengdu Rongsheng Pharmaceutical Co Ltd, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by China Biologic Products Holdings Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by China Immunotech Co Ltd, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Evrys Bio, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Fate Therapeutics Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by GlaxoSmithKline Plc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Helocyte Biosciences Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Hookipa Pharma Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Huinuo Biomedical Technology Co Ltd, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by iCELL Biotechnology Co Ltd, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Karyopharm Therapeutics Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Memo Therapeutics AG, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Merck & Co Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Microbiotix Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Moderna Inc, H2 2020
Cytomegalovirus (HHV-5) Infections - Pipeline by Nobelpharma Co Ltd, H2 2020
Cytomegalovirus (HHV-5) Infections - Dormant Projects, H2 2020
Cytomegalovirus (HHV-5) Infections - Discontinued Products, H2 2020